RhumbLine Advisers’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-68,117
| Closed | -$1.23M | – | 4316 |
|
|
2025
Q1 | $1.23M | Sell |
68,117
-2,669
| -4% | -$47.4K | ﹤0.01% | 2078 |
|
|
2024
Q4 | $1.24M | Buy |
70,786
+1,538
| +2% | +$20.8K | ﹤0.01% | 2127 |
|
|
2024
Q3 | $797K | Sell |
69,248
-3,230
| -4% | -$37.1K | ﹤0.01% | 2390 |
|
|
2024
Q2 | $820K | Sell |
72,478
-1,574
| -2% | -$20.9K | ﹤0.01% | 2347 |
|
|
2024
Q1 | $1.06M | Sell |
74,052
-162
| -0.2% | -$2.3K | ﹤0.01% | 2219 |
|
|
2023
Q4 | $1.02M | Buy |
74,214
+3,516
| +5% | +$37K | ﹤0.01% | 2240 |
|
|
2023
Q3 | $575K | Sell |
70,698
-2,352
| -3% | -$19.2K | ﹤0.01% | 2532 |
|
|
2023
Q2 | $553K | Buy |
73,050
+5,565
| +8% | +$42.5K | ﹤0.01% | 2622 |
|
|
2023
Q1 | $540K | Buy |
67,485
+430
| +0.6% | +$4.42K | ﹤0.01% | 2399 |
|
|
2022
Q4 | $762K | Buy |
67,055
+650
| +1% | +$7.09K | ﹤0.01% | 2272 |
|
|
2022
Q3 | $580K | Buy |
66,405
+4,326
| +7% | +$44.9K | ﹤0.01% | 2426 |
|
|
2022
Q2 | $618K | Buy |
62,079
+12,605
| +25% | +$127K | ﹤0.01% | 2382 |
|
|
2022
Q1 | $498K | Sell |
49,474
-5,316
| -10% | -$56.5K | ﹤0.01% | 2430 |
|
|
2021
Q4 | $695K | Buy |
54,790
+1,697
| +3% | +$22.1K | ﹤0.01% | 2366 |
|
|
2021
Q3 | $665K | Buy |
53,093
+2,025
| +4% | +$27.5K | ﹤0.01% | 2423 |
|
|
2021
Q2 | $770K | Buy |
51,068
+4,136
| +9% | +$62.1K | ﹤0.01% | 2360 |
|
|
2021
Q1 | $645K | Buy |
46,932
+50
| +0.1% | +$775 | ﹤0.01% | 2375 |
|
|
2020
Q4 | $850K | Buy |
+46,882
| New | +$723K | ﹤0.01% | 2213 |
|
RhumbLine Advisers's PTVE Position: Q2 2025 in Review
RhumbLine Advisers sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 68,117 shares — an estimated $1.23M sold.
RhumbLine Advisers first reported a position in PTVE in Q4 2020 and held it in 18 quarters. The position peaked at $1.24M in Q4 2024. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.
- RhumbLine Advisers reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
- RhumbLine Advisers sold 68,117 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $1.23M.
- RhumbLine Advisers first reported a position in Pactiv Evergreen Inc. Common stock in Q4 2020 and held it in 18 quarters.
- RhumbLine Advisers's Pactiv Evergreen Inc. Common stock position peaked at $1.24M in Q4 2024.
- 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.
Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.